50 per cent off entry fee as Cancer Research UK's Race for Life set for Highland return in 2024
Register for free to read more of the latest local news. It's easy and will only take a moment.
Cancer Research UK has announced the return of its popular Race for Life event to the Highlands in 2024 – with a half price offer for the New Year.
One of 12 similar events planned through spring and early summer, the Inverness race will take place on Sunday, with a 5K and 10K, with runners congregating at Highland Rugby Club, Canal Park.
Anyone wishing to enlist this January can claim 50 per cent off the entry fee by using the code RACE24NY.*
Every year around 34,600 people are diagnosed with cancer in Scotland.
The millions of pounds raised through Race for Life, which is open to all ages and abilities, enables scientists to find new ways to prevent, diagnose and treat the disease in all its forms.
Lisa Adams, Cancer Research UK’s spokeswoman in Scotland, said: “No matter how cancer affects us, life is worth racing for.
“Sadly nearly one in two of us will get cancer in our lifetime, but Race for Life has the power not only to transform lives, but to save them.
“We’re proud that Race for Life has already helped double survival rates in the UK.
“We’d love for as many people as possible across Inverness to join us at Race for Life.
“There is a race for everyone and it's a chance to feel the power of moving together with fellow Race for Lifers and have fun with it.
Since it began in 1994, more than 10 million people have taken part in Race for Life, funding “30 years of hope and progress”, the charity says.
Money raised has helped develop radiotherapy which benefits more than 130,000 people with cancer in the UK every year.
Cancer Research UK funded scientists led the development of the Human Papillomavirus Virus vaccine, which is expected to prevent almost 90 per cent of cervical cancers in the UK. The charity also funded many large clinical trials looking at the effectiveness of the drug tamoxifen and the research shaped the way the drug is used to treat breast cancer today.
